Quantum leads dilgence and pre-close planning for aerospace acquisition. To lead acquisition integration

March 17, 2017.  Quantum Strategic Advisors has completed the operational diligence and pre-close planning for the acquisition and integration of a space electronics manufacturer by a $3 Billion aerospace components manufacturer.  The Quantum team developed a detailed integration plan to combine manufacturing locations, business systems and organization.  Quantum has been retained to lead the integration post-close.

Quantum leads detailed global diligence for chemicals acquisition

March 3, 2017. Quantum Strategic Advisors has completed a detailed diligence for the acquisition of a global <$1 Billion chemical company by a similar sized competitor.  Quantum acted as a trusted adviser to the buyer’s Executive team, managed other diligence providers, and guided the effort in assessment of opportunities and risks in global manufacturing, sourcing, organization, SG&A and commercial integration.

Quantum completes operational diligence of a specialty chemicals company

September 9, 2016. Quantum Strategic Advisors has completed operational due diligence and synergy assessment for a publicly traded chemical company in its bid to acquire a global specialty chemicals company in coatings. The Quantum team worked closely with the bidder’s management team to assess synergies in manufacturing, sourcing, supply chain and G&A.

Quantum to lead synergy assessment in potential chemicals merger

June 27, 2016.  Quantum Strategic Advisors has been retained to lead the operational synergies assessment in the potential merger of equals of 2 global chemical companies. The confidential deal is currently in the pre-LOI stage, and further details of our work will be published if and when the transaction becomes public.

Quantum provides ODD for medical device manufacturer acquisition

June 1st 2016.  Quantum Strategic Advisors has completed the Operational Due Diligence for a PE owned medical devices manufacturer and distributor evaluating an add on acquisition of a global medical device manufacturer. The transaction is expected to close in June 2016. The Quantum team worked closely with the platform company and identified EBITDA improvement opportunities in manufacturing, sourcing, supply chain and G&A. The PE firm was very satisfied with the quality and timeliness of the work. “Thanks for the hard work–Your analysis was key in helping us gain comfort on the deal”, said the PE Principal who led the transaction.